News & Events

Press Releases
May 10, 2022
New HR-NMIBC molecular analyses to be presented at the 2022 AUA Annual Meeting Durham, NC, May 10, 2022 –  GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced today…
March 24, 2022
For two decades, scientists have been able to identify the molecular signature of specific cancers by isolating the RNA, responsible for dictating which proteins are produced and, by extension, how the cells…
March 17, 2022
New molecular analyses to be presented at the AACR Annual Meeting 2022 DURHAM, N.C.–(BUSINESS WIRE)– GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced today the upcoming oral…
December 21, 2021
The Piedmont Study, a Real-World Data Analysis in Patients Treated with Platinum Doublet Chemotherapy and/or Pembrolizumab, Identifies Predictive Biomarkers for Approved First-Line Treatments in NSCLC DURHAM, N.C.–(BUSINESS WIRE)– GeneCentric Therapeutics, a company…
December 20, 2021
GeneCentric CEO Michael Milburn discusses recent company accomplishments and the year ahead, as well as and current trends in biotech and pharma with WRAL TechWire. Read More
November 8, 2021
Proceeds to expand and commercialize growing pipeline of RNA-based molecular diagnostics Durham, N.C., Nov. 8, 2021 – GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced the…
October 22, 2021
Our new collaboration with Labcorp to develop and commercialize RNA-based oncology diagnostics was recently featured in the Triangle Business Journal. Read more at https://bizj.us/1qcgmk.
October 12, 2021
DURHAM, N.C. – October 12, 2021 — GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced a new strategic collaboration with Labcorp, a leading global life sciences…
June 2, 2021
Ongoing Collaboration with Basilea Pharmaceutica International Ltd and their Lisavanbulin Clinical Program in Glioblastoma Will Be Highlighted at ASCO DURHAM, NC / ACCESSWIRE / June 2, 2021 / GeneCentric Therapeutics, a company…
March 9, 2021
Patent Provides Framework for Further Development of Novel Lung Cancer Molecular Diagnostic Tests DURHAM, NC / ACCESSWIRE / March 9, 2021 / GeneCentric Therapeutics, a company making precision medicine more precise, announced today…
Publications & Presentations
Events
No results found.